Vascular endothelial growth factor-2 gene therapy (Corautus Genetics)

N/A

Report date: 2022/03/17 14:28:09

Base Information

Drug NameVascular endothelial growth factor-2 gene therapy (Corautus Genetics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAngiogenesis inducersVascular endothelial growth factor gene transference
TargetsVascular endothelial growth factor
Therapy Area/IndicationsVascular DiseasesAngina PectorisMyocardial Ischemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences IncVia Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsVascular DiseasesAngina PectorisMyocardial Ischemia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A